WOBURN, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today reported financial results for the first quarter ended March 31, 2023, and provided a business…Read More
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
